Plant-Based Vaccines
Plant-based vaccines represent an innovative approach to vaccine development, utilizing plants as bioreactors for producing antigens. This method harnesses the natural ability of plants to synthesize complex proteins, enabling the mass production of vaccine components that can stimulate an immune response. Plant-derived vaccines offer several advantages, including ease of production, cost-effectiveness, and stability at ambient temperatures, which is crucial for distribution in developing regions. Additionally, the use of plants minimizes the risk of contamination associated with traditional vaccine production methods. Research is ongoing to optimize the efficacy and delivery of these vaccines, with the potential to combat diseases in both humans and animals.
Srinivasa Rao Mentreddy
Alabama A&M University, United States
Mohammad Babadoost
University of Illinois, United States
Valasia Iakovoglou
UNESCO chair Con-E-Ect, International Hellenic University, Greece
Aparna B Gunjal
Dr. D.Y. Patil, Arts, Commerce and Science College, India
Anna Ponce
Bethune-Cookman University, United States
Hillary Jean Pierre
Department of Pharmaceutics, United States
Title : Biovalorization of overripe banana (Musa spp.) extract as a functional ingredient for glycemic regulation in diabesity management
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title :
Valasia Iakovoglou, UNESCO chair Con-E-Ect, International Hellenic University, Greece
Title : The antimicrobial activity of six Ocimum species against human microbial pathogens
Srinivasa Rao Mentreddy, Alabama A&M University, United States
Title : Effect of climate and weather on plant biology and biotechnology
Vijayan Gurumurthy Iyer, Techno-Economic-Environmental Study and Check Consultancy Services, India
Title : Cambial rearrangement in cycads: First evidence from a basal seed plant lineage
Anna Ponce, Bethune-Cookman University, United States
Title : Utilizing plant derived extracellular vesicles for drug delivery and therapeutic development
Hillary Jean Pierre, Department of Pharmaceutics, United States